Total Value in 2020: $22,456.84M (21 deals)

Principal company Partner company Value ($M) Technologies Date

February

Aevi Genomic Medicine Inc. Cerecor Inc. $22.00 Monoclonal antibody human; biological therapeutic; intravenous formulation; monoclonal antibody; oral formulation; parenteral formulation unspecified; small molecule therapeutic; subcutaneous formulation 2/3/20
Arthrosurface Inc. Anika Therapeutics Inc. $100.00 Implantable device deal 2/3/20
Attenua Inc. Coda Biotherapeutics Inc. Payment unspecified Small molecule therapeutic; capsule formulation; film coating; oral formulation; oral gel formulation; systemic formulation unspecified 2/5/20
Dermira Inc. Eli Lilly and Co. $1,100.00 Monoclonal antibody humanized; biological therapeutic; dermatological formulation; protein recombinant; small molecule therapeutic; subcutaneous formulation 2/20/20
Innovus Pharmaceuticals Inc. Aytu Bioscience Inc. $24.00 OTC product 2/14/20
Promedior Inc. Roche Holding AG $1,390.00 Protein recombinant; biological therapeutic; infusion; intravenous formulation 2/13/20
Pvp Biologics Inc. Takeda Pharmaceutical Co. Ltd. $330.00 Recombinant enzyme; biological therapeutic; intravenous formulation; nanoparticle formulation injectable; oral formulation; peptide; tablet formulation 2/26/20
Vibalogics Ampersand Capital Partners Payment unspecified Other technologies; biological therapeutic 2/17/20

No Comments